These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5756259)

  • 1. [On the pharmacokinetics of peruvoside. I. Comparative clinical and experimental animal studies].
    Hundeshagen H; Zeidler U; Fabel H; Garbe A; Nowak H
    Arzneimittelforschung; 1968 Dec; 18(12):1592-6. PubMed ID: 5756259
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the pharmacokinetics of peruvoside. II. Comparative studies with H3-ouabain and H3-digitoxin in guinea pigs].
    Garbe A; Nowak H
    Arzneimittelforschung; 1968 Dec; 18(12):1597-601. PubMed ID: 5756472
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue distribution, metabolism and elimination of cardiac glycosides.
    van Zwieten PA
    Ger Med Mon; 1968 Jul; 13(7):346-9. PubMed ID: 4879650
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the distribution and metabolism of H3-peruvoside in guinea pigs].
    Lüllmann H; Schaum E
    Arzneimittelforschung; 1968 Dec; 18(12):1605-9. PubMed ID: 5756261
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the blood level and secretion of radioactively labeled cardiac glycosides following intraduodenal application in the cat].
    Lahrtz H; Sattler RW; van Zwieten PA
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(3):210-22. PubMed ID: 5728874
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the tissue distribution, metabolism and excretion of cardiac glycosides].
    van Zwieten PA
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1684-7. PubMed ID: 6054325
    [No Abstract]   [Full Text] [Related]  

  • 8. [Individual glycoside therapy using serum concentration determination in canine heart failure].
    Staudacher G
    Dtsch Tierarztl Wochenschr; 1989 May; 96(6):308-10. PubMed ID: 2758985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency].
    Rietbrock N; Woodcock BG; Hrazdil U
    Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of 3H-peruvoside by guinea pig isolated atria.
    Kuschinsky K; Lüllmann H; van Zwieten PA
    Arzneimittelforschung; 1968 Dec; 18(12):1602-5. PubMed ID: 5756260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics of cardiac glycosides and clinical consequences].
    Rietbrock N; Kuhlmann J; Vöhringer HF
    Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the distribution and metabolism of 3H-peruvoside in the guinea pig].
    Schaum E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):194. PubMed ID: 4239224
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic studies on helveticosol acetonide in man].
    Zielske F; Dovidat H; Betzien G; Voigtländer W
    Arzneimittelforschung; 1971 Apr; 21(4):566-71. PubMed ID: 5108163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum level and excretion of H3 labeled cardiac glycosides under normal and pathological conditions].
    Lahrtz H; van Zwieten PA
    Radiobiol Radiother (Berl); 1969; 10(6):841. PubMed ID: 5379979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of absorption and elimination of tritium-labelled cardiac glycosides].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):206-8. PubMed ID: 5804238
    [No Abstract]   [Full Text] [Related]  

  • 17. The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.
    Lüllmann H; van Zwieten PA
    J Pharm Pharmacol; 1969 Jan; 21(1):1-8. PubMed ID: 4388183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent acquisitions in the study of the pharmacology of natural cardiotonics. I. Biotransformation].
    Lesne M
    J Pharm Belg; 1970; 25(2):83-105. PubMed ID: 4929888
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative studies on the therapeutic range of cardiac glycosides].
    Diederen W; Kadatz R
    Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of kidney or liver disorders on the serum concentration and urinary excretion of 3H-peruvoside, a tritium-labelled cardiac glycoside.
    Lahrtz H; van Zwieten PA
    Eur J Pharmacol; 1968 May; 3(2):147-52. PubMed ID: 5666010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.